Trosyd nail solution 28% - onychomycosis treatment 12ml
Estimated delivery: 1-3 business days
Estimated delivery: 1-3 business days
Information on returns and shipments
Payment methods
Medicated nail polish for the treatment of fingernail and toenail fungus.
Fungilak 50 mg/ml is a medicated nail polish for the topical treatment of onychomycosis (without matrix involvement, e.g. superficial white onychomycosis, subungual onychomycosis, affecting less than 50% of the nail surface and less than 3 nails).
Active ingredients: 1 ml of medicated nail polish contains 55.74 mg of amorolfine hydrochloride (equivalent to 50 mg of amorolfine)
Excipients: Ethanol, Ethyl acetate, Ammonium methacrylate copolymer (type A), Butyl acetate, Triacetin.
Dosage: The nail polish should be applied once a week to the affected fingernail or toenail.
Duration of treatment: 6 months (fingernails) and 9 to 12 months (toenails).
A treatment check at intervals of approximately 3 months is recommended.
Elderly: There are no specific recommendations on dosage adjustment in elderly patients.
Paediatric population: Fungilak is not recommended in infants, children and adolescents because it may cause serious side effects. Data on safety and/or efficacy are insufficient.
Method of administration: The product is intended to be applied to the nails.
Instructions for use: The user should use Fungilak as follows:
Warnings: Nail files used for treatment should no longer be used for the care of healthy nails.
After applying Fungilak, wait for Fungilak to dry (at least 10 minutes) before using any cosmetic nail polish.
Before reusing Fungilak, carefully remove any cosmetic nail polish from the nail.
During treatment, however, the use of nail polish remover should be avoided.
Fungilak is particularly effective in cases of onychomycosis in distal regions, when less than 50% of the nail surface is involved.
Treatment should continue without interruption until the nail has regenerated and the affected areas are completely healed.
The frequency required and duration of treatment depend essentially on the intensity and location of the infection.
In general, 6 months are considered for fingernails and 9 to 12 months for toenails.
Treatment monitoring at intervals of approximately 3 months is recommended.
Coexisting tinea pedis should be treated with an appropriate antifungal cream.
Fungilak should not be applied to the skin around the affected nail.
Experience is still needed in patients with inflammatory periungual changes, diabetes, circulatory diseases, malnutrition and alcoholism.
This product is flammable.
The solution must be kept away from fire and flames.
Any contact of the nail polish with eyes, ears and mucous membranes must be avoided.
With Fungilak, the use of artificial nails should be avoided during treatment.
People who work with organic solvents (thinners, petroleum ether, etc.) should wear waterproof gloves to protect the Fungilak layer on the fingernails.
Otherwise, Fungilak will be removed.
After applying Fungilak, an allergic reaction may occur, even outside the application area.
If this occurs, treatment should be stopped and a doctor should be consulted.
Fungilak should be removed immediately and carefully using nail polish remover or the alcohol wipes included in the package.
Fungilak should not be reapplied.
Since Fungilak is a natural product, it is important to avoid contact with the skin. There is no adequate clinical experience; patients under 18 years of age should not be treated with Fungilak.
Fungilak contains ethanol and may cause a burning sensation on damaged skin if it accidentally comes into contact with the surrounding skin.
Hypersensitivity to the active substance amorolfine or to any of the excipients.
Rare cases of nail disorders (e.g. nail discoloration, nail brittleness or nail splitting) have been reported following the use of medicated nail lacquer containing amorolfine.
These reactions may also be attributed to onychomycosis itself.
| System organ class | Frequency | Adverse reactions |
| Immune system disorders | Not known* | Hypersensitivity reactions (including those outside the application site, which may be associated with swelling of the face, lips, tongue or throat, breathing problems and/or severe skin rashes)* |
| Skin and subcutaneous tissue disorders | Rare (≥ 1/10,000 to < 1/1,000) | Nail disorder, nail discoloration, onychoclasis (nail breakage), onychorrhesis (nail brittleness) |
| Very rare (< 1/10,000) | Skin burning sensation | |
| Not known* | Erythema*, pruritus*, contact dermatitis* (irritative or allergic) (including allergic contact dermatitis, with spreading reaction), urticaria*, blisters* |
*Experience gained in the period after marketing.
No cases of overdose have been reported.
Amorolfine is intended for topical use.
In case of accidental oral ingestion, appropriate gastric emptying measures can be taken.
Pregnancy: Since systemic exposure to amorolfine is negligible, amorolfine is not expected to cause any effects during pregnancy, therefore Fungilak can be used during pregnancy.
Breastfeeding: Since systemic exposure to amorolfine in breastfeeding women is negligible, amorolfine is not expected to cause any effects on newborns/infants, therefore FUNGILAK can be used during pregnancy. be used during breastfeeding.
Fertility: Since systemic exposure to amorolfine is negligible, amorolfine is not expected to cause any effects on fertility.
Do not store above 30°C.
Shelf life after first opening the bottle: 6 months.
Package contents:
This product has been on sale since 09/09/2022
In the last 30 days, the product's lowest price was 21,25 €